Previous close | 12.47 |
Open | 12.34 |
Bid | 0.00 x 800 |
Ask | 0.00 x 1200 |
Day's range | 12.10 - 12.44 |
52-week range | 11.84 - 40.68 |
Volume | |
Avg. volume | 809,322 |
Market cap | 607.892M |
Beta (5Y monthly) | 1.10 |
PE ratio (TTM) | 72.00 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.24 (1.96%) |
Ex-dividend date | 23 Feb 2024 |
1y target est | N/A |
PROVO, Utah, April 03, 2024--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release first quarter 2024 results after the market closes on Wednesday, May 8. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m. ET. During the call, management will discuss recent results and upcoming business initiatives.
Nu Skin Enterprises (NYSE: NUS), a global beauty and wellness leader, today introduced Nu Skin RenuSpa iO, a smart beauty and wellness device designed to promote overall wellness and body confidence through skin stimulation. RenuSpa iO is an FDA-cleared microcurrent body device and the latest innovation from the world's best-selling brand for beauty device systems for six consecutive years.*
PROVO, Utah, February 14, 2024--Nu Skin Enterprises Inc. (NYSE: NUS) today announced fourth quarter and full-year 2023 results slightly above its latest guidance.